tradingkey.logo
搜索

Microbot Medical Inc

MBOT
添加自选
1.910USD
0.0000.00%
收盘 07/02, 13:00美东报价延迟15分钟
125.74M总市值
亏损市盈率 TTM

Microbot Medical Inc

1.910
0.0000.00%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

0.00%

5天

+7.91%

1月

-4.98%

6月

-9.48%

今年开始到现在

-4.50%

1年

-23.60%

关键数据
1.920今开
1.979最高
774.48K成交量
亏损市盈率 TTM
亏损市盈率动
--股息TTM
1.18%换手率
1.910昨收
1.870最低
1.09M成交额
亏损市盈率静
1.61市净率
0.00%股息率 TTM
-26.09%ROA
4.67052周最高
1.40量比
-11.44M净利润
65.83M总股本
-0.2580每股收益TTM
1.03Beta
-27.58%ROE
1.60052周最低
5.71%振幅
1.90%毛利率
125.74M总市值
-0.71回报/风险
4.26%风险率

TradingKey Microbot Medical Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Microbot Medical Inc当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在生物技术与医疗研究行业排名134/387位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价7.00。中期看,股价处于下降通道。近一个月,市场表现一般,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

Microbot Medical Inc评分

相关信息

行业排名
134 / 387
全市场排名
266 / 4565
所属行业
生物技术与医疗研究

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
中性

Microbot Medical Inc亮点

亮点风险
Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
利润高增长
公司净利润处于行业前列,最新年度总收入0.00美元
估值低估
公司最新PE估值-7.40,处于3年历史低位
机构加仓
最新机构持股15.51M股,环比增加25.62%
活跃度降低
近期活跃度降低,过去20天平均换手率-0.67

分析师目标

根据 3 位分析师
买入
评级
7.000
目标均价
+274.33%
涨幅空间

Microbot Medical Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Microbot Medical Inc简介

Microbot Medical Inc. is a pre-commercial stage medical technology company. It has developed the single-use, fully disposable endovascular robotic system, which aims to eliminate traditional barriers to accessing advanced robotic systems. It specializes in the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, it is developing a fully disposable robot for various endovascular interventional procedures. The LIBERTY Endovascular Robotic Surgical System is designed to maneuver guidewires and over-the-wire devices (such as microcatheters) within the body’s vasculature. It eliminates the need for extensive capital equipment requiring dedicated Cath-lab rooms as well as dedicated staff. Its addressable markets for the LIBERTY Endovascular Robotic Surgical System include the peripheral interventional radiology, interventional cardiology and interventional neuroradiology markets.
公司代码MBOT
公司Microbot Medical Inc
CEOGadot (Harel)
网址http://www.microbotmedical.com/

常见问题

Microbot Medical Inc(MBOT)的当前股价是多少?

Microbot Medical Inc(MBOT)的当前股价是 1.91。

Microbot Medical Inc的股票代码是什么?

Microbot Medical Inc的股票代码是MBOT。

Microbot Medical Inc股票的52周最高点是多少?

Microbot Medical Inc股票的52周最高点是4.67。

Microbot Medical Inc股票的52周最低点是多少?

Microbot Medical Inc股票的52周最低点是1.60。

Microbot Medical Inc的市值是多少?

Microbot Medical Inc的市值是125.74M。

现在Microbot Medical Inc(MBOT)的股票是买入、持有还是卖出?

根据分析师评级,Microbot Medical Inc(MBOT)的总体评级为买入,目标价格为7.00。

Microbot Medical Inc(MBOT)股票的每股收益(EPS TTM)是多少

Microbot Medical Inc(MBOT)股票的每股收益(EPS TTM)是-0.29。